• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer.

作者信息

Tran William T, Lu Fang-I, Salgado Roberto

机构信息

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.

Department of Radiation Oncology, University of Toronto, Toronto, Canada.

出版信息

Expert Rev Anticancer Ther. 2021 Dec;21(12):1299-1301. doi: 10.1080/14737140.2021.1953987. Epub 2021 Jul 24.

DOI:10.1080/14737140.2021.1953987
PMID:34236013
Abstract
摘要

相似文献

1
Tumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer.肿瘤浸润淋巴细胞：乳腺癌标准生物标志物的当前研究途径
Expert Rev Anticancer Ther. 2021 Dec;21(12):1299-1301. doi: 10.1080/14737140.2021.1953987. Epub 2021 Jul 24.
2
A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.基于 TCGA 的肿瘤微环境中浸润性乳腺癌新型免疫和基质相关预后标志物研究。
Front Endocrinol (Lausanne). 2021 Nov 18;12:774244. doi: 10.3389/fendo.2021.774244. eCollection 2021.
3
Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.初次复发时转移性三阴性乳腺癌的肿瘤浸润淋巴细胞比其匹配的原发性乳腺癌肿瘤更少：一项初步研究。
Hum Pathol. 2013 Oct;44(10):2055-63. doi: 10.1016/j.humpath.2013.03.010. Epub 2013 May 21.
4
Relevance of tumor-infiltrating lymphocytes in breast cancer.肿瘤浸润淋巴细胞在乳腺癌中的相关性
BMC Med. 2015 Aug 24;13:202. doi: 10.1186/s12916-015-0431-3.
5
Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.乳腺癌微环境中的免疫浸润：检测、特征及临床意义
Breast Cancer. 2017 Jan;24(1):3-15. doi: 10.1007/s12282-016-0698-z. Epub 2016 May 2.
6
Some concerns about the prognostic significance of non-lymphoid immune cells of the tumor microenvironment in breast carcinomas.关于乳腺癌肿瘤微环境中非淋巴细胞免疫细胞的预后意义的一些担忧。
Ann Diagn Pathol. 2023 Oct;66:152164. doi: 10.1016/j.anndiagpath.2023.152164. Epub 2023 May 18.
7
Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.鉴定基质ColXα1和肿瘤浸润淋巴细胞作为雌激素受体阳性/人表皮生长因子受体2阳性乳腺癌新辅助治疗的潜在预测标志物。
BMC Cancer. 2016 Apr 18;16:274. doi: 10.1186/s12885-016-2302-5.
8
Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.肿瘤浸润淋巴细胞（TILs）的形态学评估以研究浸润性乳腺癌的免疫原性、揭示淋巴细胞网络并辅助复发预测：一项回顾性研究
Int J Mol Sci. 2017 Sep 8;18(9):1936. doi: 10.3390/ijms18091936.
9
Characterization of the relationship between FLI1 and immune infiltrate level in tumour immune microenvironment for breast cancer.乳腺癌肿瘤免疫微环境中 FLI1 与免疫浸润水平关系的特征分析。
J Cell Mol Med. 2020 May;24(10):5501-5514. doi: 10.1111/jcmm.15205. Epub 2020 Apr 5.
10
ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.ATP2C2 有望定义乳腺癌中的肿瘤微环境。
Front Immunol. 2021 Apr 14;12:657950. doi: 10.3389/fimmu.2021.657950. eCollection 2021.

引用本文的文献

1
PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy.新辅助化疗后不完全病理缓解的乳腺浸润性导管癌中 PD-L1 的表达。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221078433. doi: 10.1177/03946320221078433.